[HTML][HTML] Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries

C Selvaraj, I Chandra, SK Singh - Molecular diversity, 2021 - Springer
The global spread of COVID-19 has raised the importance of pharmaceutical drug
development as intractable and hot research. Developing new drug molecules to overcome …

[HTML][HTML] Design of SARS-CoV-2 main protease inhibitors using artificial intelligence and molecular dynamic simulations

L Elend, L Jacobsen, T Cofala, J Prellberg, T Teusch… - Molecules, 2022 - mdpi.com
Drug design is a time-consuming and cumbersome process due to the vast search space of
drug-like molecules and the difficulty of investigating atomic and electronic interactions. The …

Deep Learning Approach for Discovery of In Silico Drugs for Combating COVID‐19

N Jha, D Prashar, M Rashid, M Shafiq… - Journal of healthcare …, 2021 - Wiley Online Library
Early diagnosis of pandemic diseases such as COVID‐19 can prove beneficial in dealing
with difficult situations and helping radiologists and other experts manage staffing more …

Systemic In Silico Screening in Drug Discovery for Coronavirus Disease (COVID-19) with an Online Interactive Web Server

C Xu, Z Ke, C Liu, Z Wang, D Liu, L Zhang… - Journal of Chemical …, 2020 - ACS Publications
The emergence of the new coronavirus (nCoV-19) has impacted human health on a global
scale, while the interaction between the virus and the host is the foundation of the disease …

Artificial intelligence based drug discovery techniques for covid-19 detection

K Arora, AS Bist - Aptisi Transactions on Technopreneurship (ATT), 2020 - att.aptisi.or.id
Recent advancements in the area of drug discovery using artificial intelligence made it
possible to speed up the hunt for new pharmaceuticals. Drugs like arbidol, atazanavir …

In silico studies on therapeutic agents for COVID-19: Drug repurposing approach

B Shah, P Modi, SR Sagar - Life sciences, 2020 - Elsevier
Aims The severe acute respiratory syndrome coronavirus 2, better known as COVID-19 has
become the current health concern to the entire world. Initially appeared in Wuhan, China …

Deep learning techniques and COVID-19 drug discovery: Fundamentals, state-of-the-art and future directions

MB Jamshidi, A Lalbakhsh, J Talla, Z Peroutka… - … Technologies During the …, 2021 - Springer
The world is in a frustrating situation, which is exacerbating due to the time-consuming
process of the COVID-19 vaccine design and production. This chapter provides a …

[HTML][HTML] Exploiting cheminformatic and machine learning to navigate the available chemical space of potential small molecule inhibitors of SARS-CoV-2

A Kumar, S Loharch, S Kumar, RP Ringe… - Computational and …, 2021 - Elsevier
The current life-threatening and tenacious pandemic eruption of coronavirus disease in
2019 (COVID-19) has posed a significant global hazard concerning high mortality rate …

Applications of artificial intelligence to drug design and discovery in the big data era: a comprehensive review

N Tripathi, MK Goshisht, SK Sahu, C Arora - Molecular Diversity, 2021 - Springer
Artificial intelligence (AI) renders cutting-edge applications in diverse sectors of society. Due
to substantial progress in high-performance computing, the development of superior …

[HTML][HTML] Overview of current state of research on the application of artificial intelligence techniques for COVID-19

V Kumar, D Singh, M Kaur, R Damaševičius - PeerJ computer science, 2021 - peerj.com
Background Until now, there are still a limited number of resources available to predict and
diagnose COVID-19 disease. The design of novel drug-drug interaction for COVID-19 …